EREG and cancer: Neufert et al. [91] found that CAFs were the main producer of EREG in the tumor microenvironment of colitis-associated cancers and that EREG deficiency impaired colitis-associated tumor growth in mice, thereby indicating the tumor-promoting role of CAF-derived EREG.